JYHZ2100609 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | License Renew | 2021-08-16 | | | | | view |
JYHZ2100608 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | License Renew | 2021-08-16 | | | | | view |
JYHZ2100607 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | License Renew | 2021-08-16 | | | | | view |
JYHZ2100606 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | License Renew | 2021-08-16 | | | | | view |
JYHZ2100605 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | License Renew | 2021-08-16 | | | | | view |
JYHF2000084 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-09-03 | 上海勃林格殷格翰药业有限公司 | Boehringer Ingelheim Shanghai Pharmaceuticals Co Ltd | Filed | 2020-09-11 | view |
JYHF1700104 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-10-23 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-11-21 | view |
JYHF1700103 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2017-10-23 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Certificate Issued | 2017-11-21 | view |
JYHB2300717 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2023-12-14 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2300716 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2023-12-14 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2300083 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2023-02-01 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2300082 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2023-02-01 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2200337 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-07-02 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2200336 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-07-02 | | Boehringer Ingelheim International GmbH | | | view |
JYHB2200214 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-04-15 | | | | | view |
JYHB2200213 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-04-15 | | | | | view |
JYHB2200212 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-04-15 | | | | | view |
JYHB2200211 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-04-15 | | | | | view |
JYHB2200210 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2022-04-18 | | | | | view |
JYHB2000862 | 恩格列净片 | empagliflozin | Tablet | Chemical Drugs | Supplementary Application | 2020-06-16 | 勃林格殷格翰(中国)投资有限公司 | Boehringer Ingelheim (China) Investment Co Ltd | Filed | 2020-06-22 | view |